These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22278214)

  • 41. Compound Heterozygosity of β-Thalassemia and the Sickle Cell Hemoglobin in Various Populations of Chhattisgarh State, India.
    Jha AN; Mishra H; Verma HK; Pandey I; Lakkakula BVKS
    Hemoglobin; 2018 Mar; 42(2):84-90. PubMed ID: 30200838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neonatal screening for sickle cell disease at the Nice University Hospital: the last 8 years].
    Berthet S; Monpoux F; Soummer AM; Bérard E; Sarles J; Badens C
    Arch Pediatr; 2010 Dec; 17(12):1652-6. PubMed ID: 21087846
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Trends in sickle cell trait and disease screening in the Republic of Uganda, 2014-2019.
    Hernandez AG; Kiyaga C; Howard TA; Ssewanyana I; Ndeezi G; Aceng JR; Ware RE
    Trop Med Int Health; 2021 Jan; 26(1):23-32. PubMed ID: 33151598
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of sickle cell disease among Grenadian newborns.
    Antoine M; Lee K; Donald T; Belfon Y; Drigo A; Polson S; Martin F; Mitchell G; Etienne-Julan M; Hardy-Dessources MD
    J Med Screen; 2018 Mar; 25(1):49-50. PubMed ID: 29183229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sickle cell anemia--molecular diagnosis and prenatal counseling: SGPGI experience.
    Kumar R; Panigrahi I; Dalal A; Agarwal S
    Indian J Pediatr; 2012 Jan; 79(1):68-74. PubMed ID: 21713598
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central Malawi.
    Tegha G; Topazian HM; Kamthunzi P; Howard T; Tembo Z; Mvalo T; Chome N; Kumwenda W; Mkochi T; Hernandez A; Ataga KI; Hoffman IF; Ware RE
    Int J Public Health; 2021; 66():629338. PubMed ID: 34335138
    [No Abstract]   [Full Text] [Related]  

  • 47. Neonatal haemoglobinopathy screening: review of a 10-year programme in Brussels.
    Gulbis B; Ferster A; Cotton F; Lebouchard MP; Cochaux P; Vertongen F
    J Med Screen; 2006; 13(2):76-8. PubMed ID: 16792829
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of a point-of-care rapid diagnostic test kit (SICKLECHECK) for screening of sickle cell diseases.
    Purohit P; Parida C; Martha TK; Bholo S; Naik A; Behera SK
    PLoS One; 2024; 19(8):e0309045. PubMed ID: 39150948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lessons from pilot studies.
    Tshilolo L; Kafando E; Sawadogo M; Cotton F; Vertongen F; Ferster A; Gulbis B
    Public Health; 2008 Sep; 122(9):933-41. PubMed ID: 18555498
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neonatal screening and genetic counseling for sickle cell trait.
    Grossman LK; Holtzman NA; Charney E; Schwartz AD
    Am J Dis Child; 1985 Mar; 139(3):241-4. PubMed ID: 3976605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease. Cooperative Study of Sickle Cell Disease.
    Brown AK; Sleeper LA; Miller ST; Pegelow CH; Gill FM; Waclawiw MA
    Arch Pediatr Adolesc Med; 1994 Aug; 148(8):796-804. PubMed ID: 7519102
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle-cell disease and sickle-cell thalassemia.
    Sahli CA; Bibi A; Ouali F; Fredj SH; Dakhlaoui B; Othmani R; Laouini N; Jouini L; Ouenniche F; Siala H; Touhami I; Becher M; Fattoum S; Toumi Nel H; Messaoud T
    Clin Chem Lab Med; 2013 Nov; 51(11):2115-24. PubMed ID: 23800659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Newborn screening for sickle cell disorders using tandem mass spectrometry: three years' experience of using a protocol to detect only the disease states.
    Moat SJ; Rees D; George RS; King L; Dodd A; Ifederu A; Ramgoolam T; Hillier S
    Ann Clin Biochem; 2017 Sep; 54(5):601-611. PubMed ID: 28656815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neonatal haemoglobinopathy screening in Belgium.
    Gulbis B; Cotton F; Ferster A; Ketelslegers O; Dresse MF; Rongé-Collard E; Minon JM; Lé PQ; Vertongen F
    J Clin Pathol; 2009 Jan; 62(1):49-52. PubMed ID: 19103861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia.
    Paulukonis ST; Snyder A; Smeltzer MP; Sutaria AN; Hurden I; Latta K; Chennuri S; Vichinsky E; Reeves SL
    J Pediatr Hematol Oncol; 2023 May; 45(4):174-180. PubMed ID: 37083273
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High birth prevalence of sickle cell disease in Northwestern Tanzania.
    Ambrose EE; Makani J; Chami N; Masoza T; Kabyemera R; Peck RN; Kamugisha E; Manjurano A; Kayange N; Smart LR
    Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28766840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Neonatal screening of sickle cell disease in the Balearic Islands Autonomous Community. Pilot study in anonymous unrelated population].
    López-Escribano H; Vila Vidal M; Barceló Bennassar A; Riesco Prieto M; Ayllón Gatnau O
    An Pediatr (Barc); 2009 May; 70(5):429-33. PubMed ID: 19376755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MALDI-MS in first-line screening of newborns for sickle cell disease: results from a prospective study in comparison to HPLC.
    El Osta M; Benoist JF; Naubourg P; Bonacorsi S; Messine R; Ducoroy P; Allaf B
    Clin Chem Lab Med; 2024 May; 62(6):1149-1157. PubMed ID: 38353144
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Starting neonatal screening for haemoglobinopathies in The Netherlands.
    Giordano PC
    J Clin Pathol; 2009 Jan; 62(1):18-21. PubMed ID: 19103852
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Newborn screening for sickle cell disease: 4 years of experience from California's newborn screening program.
    Shafer FE; Lorey F; Cunningham GC; Klumpp C; Vichinsky E; Lubin B
    J Pediatr Hematol Oncol; 1996 Feb; 18(1):36-41. PubMed ID: 8556368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.